Vivostat A/S

Vivostat develop, manufacture and market the Vivostat system, which is sold through direct sales channels and distributors throughout Europe, Asia and the Middle East. The uniqueness of the Vivostat system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF) to prevent/stop bleeding or stimulate the healing of chronic wounds. With the Vivostat system It is also possible to co-deliver a desired antibiotic with Vivostat Fibrin Sealant or Vivostat PRF. The fully automated Vivostat system consists of three components: 1. The Processor Unit The Processor Unit is used to...

Fibrin,prf,autologous,wound,wound care,platelets,platelet rich fibrin,diabetic wounds,co-application,abdominal surgery,urology,air leakages,sealing,medical devices,tissue regeneration,co-delivery,vivostat,neurosurgery,cardiac surgery,fistula,and burns

Vivostat a/s operates in the Medical equipment manufacturing industry.

Vivostat a/s's revenue is 11m - 100m

Vivostat a/s has 11 - 50 employees.